PAROXETINE HYDROCHLORIDE (paroxetine hydrochloride hemihydrate) by Viatris (2) is (mdd), panic disorder (pd), social anxiety disorder (sad), and premenstrual dysphoric disorder (pmdd) is unknown, but is presumed to be linked to potentiation of serotonergic activity in the central nervous system resulting from inhibition of neuronal reuptake of serotonin (5-ht). Approved for anxiety, anxiety. First approved in 2018.
Drug data last refreshed 20h ago
(MDD), panic disorder (PD), social anxiety disorder (SAD), and premenstrual dysphoric disorder (PMDD) is unknown, but is presumed to be linked to potentiation of serotonergic activity in the central nervous system resulting from inhibition of neuronal reuptake of serotonin (5-HT).
Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)
Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions
Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions
BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder
Worked on PAROXETINE HYDROCHLORIDE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.